Discussion:
With the ongoing Outbreak of COVID-19, we noticed a significant increase in ischemic stroke incidence among patients with a severe inflammatory response to the SARS-COV-2-induced ARDS admitted to our high dependency and intensive care units [table1] . The authors observed SARS-COV-2’s associated ischemic stroke with the ongoing recognition of the neurological manifestations of COVID-19. [4,5,16] Mao et al. described these manifestations in a retrospective, observational case series of 219 patients in Wuhan, China, 41.1% of which had severe pulmonary disease, 36.4% elicited a neurological manifestation of which 5.7% attributed to the cerebrovascular disease.[16]
In a retrospective cohort study of a 1,916 patient who visited the emergency department in two academic New York hospitals, Mekler et al. found that 36 patients had an acute ischemic stroke in SARS-COV2 infection (1.6%; 95% CI, 1.1%-2.3%) in comparison to 3 out of 1,486 patients with influenza viral infections (0.2%; 95% CI, 0.0%-0.6%).